DSG2 and Arrhythmogenic right ventricular dysplasia: It has been proven that mutations in the glycosylation sites of DSG2 have been associated with weakened myocardial desmosomes in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) [482,483].